{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nWatson JA. et al, (2020), eLife, 9
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nWattanakul T. et al, (2020), Antimicrobial Agents and Chemotherapy, 64
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDing J. et al, (2020), Clinical pharmacology and therapeutics, 107, 1179 - 1188
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKobylinski KC. et al, (2020), Clinical Pharmacology & Therapeutics, 107, 1221 - 1230
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nWatson JA. et al, (2020)
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFrancis J. et al, (2020), Antimicrobial agents and chemotherapy, 64
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nde Kock M. et al, (2020), CPT: pharmacometrics & systems pharmacology, 9, 238 - 239
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDing J. et al, (2020), Clinical pharmacology and therapeutics, 107, 1023 - 1033
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nvan der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLeopold S. et al, (2020), SSRN Electronic Journal
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nChan XHS. et al, (2020), PLOS Medicine, 17, e1003040 - e1003040
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nAbdullahi ST. et al, (2020), Journal of clinical pharmacology, 60, 351 - 360
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nOnyamboko MA. et al, (2020), Antimicrobial Agents and Chemotherapy, 64
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nAbdullahi ST. et al, (2020), Antimicrobial Agents and Chemotherapy, 64
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nUrsing J. et al, (2020), Antimicrobial Agents and Chemotherapy, 64
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBirgersson S. et al, (2020), Wellcome Open Research, 4, 45 - 45
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nvon Seidlein L. et al, (2020), Human Vaccines & Immunotherapeutics, 16, 33 - 41
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nByakika-Kibwika P. et al, (2019), BMC infectious diseases, 19
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \n(2019), Malaria Journal, 18
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nChotsiri P. et al, (2019), Nature Communications, 10
\n \n \n \n\n \n
\n \n \n